Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aevi Genomic Medicine Inc (NASDAQ:GNMX)

1.60
Delayed Data
As of Mar 24
 -0.02 / -1.23%
Today’s Change
1.50
Today|||52-Week Range
6.89
-69.11%
Year-to-Date
Biotech Premarket Movers:
Mar 20 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close1.62
Today’s open1.61
Day’s range1.59 - 1.71
Volume885,508
Average volume (3 months)485,860
Market cap$59.4M
Dividend yield--
Data as of 3:59pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)+17.93%
Earnings growth (this year)+6.89%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.70

Competitors

 Today’s
change
Today’s
% change
NTECIntec Pharma Ltd+0.05+0.99%
ZSANZosano Pharma Corp-0.04-2.26%
OREXOrexigen Therapeutic...-0.02-0.50%
NBYNovaBay Pharmaceutic...0.000.00%
Data as of 3:59pm ET, 03/24/2017

Financials

Next reporting dateMay 11, 2017
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$0.00
Annual profit (last year)-$41.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael F. Cola
CFO, Principal Financial &
Accounting Officer
Brian D. Piper
Corporate headquarters
Wayne, Pennsylvania

Forecasts


Search for Jobs